
Lexicon Pharmaceuticals LXRX
€ 1.34
6.8%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Lexicon Pharmaceuticals P/E 2011-2026 | LXRX
P/E Jährlich Lexicon Pharmaceuticals
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.575 | -2.65 | -4.47 | -6.54 | - | 2.61 | -3.87 | -9 | -10 | -225 | -4.85 | -9.02 | -9.38 | -4.37 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.61 | -225 | -22.1 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Alector
ALEC
|
-1.73 | $ 2.13 | -12.55 % | $ 219 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
BioCardia
BCDA
|
-0.769 | $ 1.37 | 6.2 % | $ 29 M | ||
|
Black Diamond Therapeutics
BDTX
|
-1.49 | $ 2.4 | -2.83 % | $ 132 M | ||
|
BioLineRx Ltd.
BLRX
|
-50 | $ 2.8 | -1.06 % | $ 908 M | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
BioXcel Therapeutics
BTAI
|
-0.0902 | $ 1.64 | -1.8 % | $ 4.16 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
BeyondSpring
BYSI
|
-5.04 | $ 1.44 | 6.3 % | $ 58.1 M | ||
|
Cabaletta Bio
CABA
|
-0.303 | $ 3.34 | 0.6 % | $ 3.9 M | ||
|
AbCellera Biologics
ABCL
|
-6.57 | $ 3.7 | 2.49 % | $ 1.11 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Codexis
CDXS
|
-4.46 | $ 1.05 | 3.47 % | $ 77.1 M | ||
|
Cerus Corporation
CERS
|
-14.4 | $ 2.6 | 1.56 % | $ 480 M | ||
|
Certara
CERT
|
-676 | $ 7.17 | 1.27 % | $ 1.15 B | ||
|
Cullinan Management
CGEM
|
-3.04 | $ 15.91 | 2.65 % | $ 931 M | ||
|
Compugen Ltd.
CGEN
|
-10.4 | $ 2.28 | 25.97 % | $ 204 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Coherus BioSciences
CHRS
|
-0.879 | $ 1.66 | -0.9 % | $ 156 M | ||
|
Adverum Biotechnologies
ADVM
|
-0.583 | - | - | $ 86.2 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-12.9 | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Cellectis S.A.
CLLS
|
-1.62 | $ 3.88 | - | $ 116 M | ||
|
Allena Pharmaceuticals
ALNA
|
-2.17 | - | 3.16 % | $ 1.9 M | ||
|
Aileron Therapeutics
ALRN
|
-0.608 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
CNS Pharmaceuticals
CNSP
|
-0.035 | $ 3.1 | -0.44 % | $ 1.18 M | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Cocrystal Pharma
COCP
|
-0.825 | $ 1.02 | -0.97 % | $ 10.4 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
Collegium Pharmaceutical
COLL
|
82.4 | $ 42.0 | 0.79 % | $ 1.33 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
37.7 | $ 35.61 | -0.25 % | $ 3.7 B | ||
|
Athira Pharma
ATHA
|
-0.167 | - | - | $ 269 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.136 | - | 17.91 % | $ 11.1 M |